South Korea Medical Disposables Market

ID: MRFR/MED/50873-HCR
200 Pages
Vikita Thakur
Last Updated: February 06, 2026
South Korea Medical Disposables Market Research Report: Size, Share, Trend Analysis By Product (Wound Management Products, Drug Delivery Products, Diagnostic and Laboratory Disposables, Dialysis Disposable, Incontinence Products, Respiratory Supplies, Sterilization Supplies, Non-woven Disposables, Disposable Masks, Disposable Eye Gear, Disposable Gloves, Hand Sanitizers, Others), By Raw Material (Plastic Resin, Nonwoven Material, Rubber, Paper and Paperboard, Metals, Glass, Others) and By End Use (Hospitals, Home Healthcare, Outpatient/Primary Care Facilities, Others) - Growth Outlook & Industry Forecast 2025 To 2035
South Korea Medical Disposables Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.39%
2024 Market Size$ 6.93 Billion
2025 Market Size$ 7.3 Billion
2035 Market Size$ 12.35 Billion
Key Players
Medtronic
Johnson & Johnson
B. Braun Melsungen AG
Cardinal Health
Smith & Nephew
3M
Trends
  • Rising Demand for Infection Control Products
  • Technological Advancements in Product Design
  • Government Support for Healthcare Infrastructure
Opportunities
  • Regulatory Support and Standards
  • Increasing Healthcare Expenditure
  • Aging Population and Chronic Diseases
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Product (USD Billion)
      1. 4.1.1 Wound Management Products
      2. 4.1.2 Drug Delivery Products
      3. 4.1.3 Diagnostic and Laboratory Disposables
      4. 4.1.4 Dialysis Disposable
      5. 4.1.5 Incontinence Products
      6. 4.1.6 Respiratory Supplies
      7. 4.1.7 Sterilization Supplies
      8. 4.1.8 Non-woven Disposables
      9. 4.1.9 Disposable Masks
      10. 4.1.10 Disposable Eye Gear
      11. 4.1.11 Disposable Gloves
      12. 4.1.12 Hand Sanitizers
      13. 4.1.13 Others
    2. 4.2 Pharmaceutical, BY Raw Material (USD Billion)
      1. 4.2.1 Plastic Resin
      2. 4.2.2 Nonwoven Material
      3. 4.2.3 Rubber
      4. 4.2.4 Paper and Paperboard
      5. 4.2.5 Metals
      6. 4.2.6 Glass
      7. 4.2.7 Others
    3. 4.3 Pharmaceutical, BY End Use (USD Billion)
      1. 4.3.1 Hospitals
      2. 4.3.2 Home Healthcare
      3. 4.3.3 Outpatient/Primary Care Facilities
      4. 4.3.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 B. Braun Melsungen AG (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cardinal Health (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Smith & Nephew (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 3M (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Halyard Health (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Terumo Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 ConvaTec Group (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY RAW MATERIAL
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USE
    5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
    8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    11. 6.11 PHARMACEUTICAL, BY PRODUCT, 2024 (% SHARE)
    12. 6.12 PHARMACEUTICAL, BY PRODUCT, 2024 TO 2035 (USD Billion)
    13. 6.13 PHARMACEUTICAL, BY RAW MATERIAL, 2024 (% SHARE)
    14. 6.14 PHARMACEUTICAL, BY RAW MATERIAL, 2024 TO 2035 (USD Billion)
    15. 6.15 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
    16. 6.16 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Billion)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.2.2 BY RAW MATERIAL, 2025-2035 (USD Billion)
      3. 7.2.3 BY END USE, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South Korea South Korea Medical Disposables Market Segmentation

South Korea Medical Disposables Market By Product (USD Billion, 2025-2035)

  • Wound Management Products
  • Drug Delivery Products
  • Diagnostic and Laboratory Disposables
  • Dialysis Disposable
  • Incontinence Products
  • Respiratory Supplies
  • Sterilization Supplies
  • Non-woven Disposables
  • Disposable Masks
  • Disposable Eye Gear
  • Disposable Gloves
  • Hand Sanitizers
  • Others

South Korea Medical Disposables Market By Raw Material (USD Billion, 2025-2035)

  • Plastic Resin
  • Nonwoven Material
  • Rubber
  • Paper and Paperboard
  • Metals
  • Glass
  • Others

South Korea Medical Disposables Market By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Home South Korea Medical Disposables Market
  • Outpatient/Primary Care Facilities
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.